뉴로모듈레이션 기기 시장 : 기기 유형별, 용도별, 최종사용자별, 지역별

Neuromodulation Devices Market is estimated to be valued at USD 18.71 Bn in 2025 and is expected to reach USD 50.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.2% from 2025 to 2032.

Neuromodulation devices stimulate nerves with electrical signals, pharmaceutical agents, or other forms of energy neurostimulation that provides pain relief by blocking the transmission of pain signals before they reach the brain. Neuromodulation devices are implantable medical devices, which introduce therapeutic solutions to some chronic diseases through electric stimulation or medication. Neuromodulation devices are segmented into five major technologies, namely: spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices and gastric electric stimulation devices. Neuromodulation devices deliver electrical impulses to the nerves and the brain by treating disorders such as deafness, chronic pain, and Parkinson's disease. Lectrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has a property to activate electrical impulse and transmit signals to the electrodes of neuromodulation device, which causes depolarization and, in turn, reduces pain and improves the muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Market Dynamics

Increasing product approvals by regulatory authorities are expected to drive the global neuromodulation devices market growth over the forecast period. For instance, on April 19, 2023, BIOTRONIK, a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval for Prospera, a Spinal Cord Stimulation (SCS) system. The system features RESONANCE, the first and multiphase stimulation paradigm, paired with Embrace One, a patient-centric care model that makes proactive care possible by offering automatic, objective, daily remote monitoring, and ongoing management and support. This approval marks the launch of the company's new business segment, BIOTRONIK Neuro.

Key features of the study

• This report provides an in-depth analysis of the global neuromodulation devices market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuromodulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., and Synapse Biomedical Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
• The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuromodulation devices market

Market Segmentation

• Global Neuromodulation Devices Market, Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
• Global Neuromodulation Devices Market, Application
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism and GIT Management
  • Others (Incontinence Management, etc.)
• Global Neuromodulation Devices Market, By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Others (Nursing Facilities, etc.)
• Global Neuromodulation Devices Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Global Neuromodulation Devices Market Companies
  • Medtronic
  • BD
  • LivaNova
  • Axonics, Inc.
  • ShiraTronics
  • Abbott
  • Bioventus
  • Neuronetics
  • NEVRO CORP
  • Integer Holdings Corporation
  • BIOTRONIK
  • NeuroPace, Inc.
  • NeuroMetrix, Inc.
  • Helius Medical Technologies, Inc.
  • Synapse Biomedical Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Device Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Regulatory Guidelines
• Product launches
• Key Development
• PEST Analysis
• PORTER's Analysis
• Regulatory Scenario
• Mergers and Acquisitions
• Manufacturer Revenue
• Healthcare Spending by Country

4. Global Neuromodulation Devices Market, By Device Type, 2020-2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Spinal Cord Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Deep Brain Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Sacral Nerve Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Vagus Nerve Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Gastric Electric Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

5. Global Neuromodulation Devices Market, By Application, 2020-2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Neurological and Movement Disorder Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Musculoskeletal Disorder Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Metabolism and GIT Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others (Incontinence Management, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Neuromodulation Devices Market, By End User, 2020-2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Specialized Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others (Physiotherapy Centers, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Neuromodulation Devices Market, By Region, 2020-2032, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020- 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2020-2032, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BD
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LivaNova
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Axonics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ShiraTronics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bioventus
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Neuronetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NEVRO CORP
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Integer Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BIOTRONIK
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NeuroPace, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NeuroMetrix, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Helius Medical Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Synapse Biomedical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us